Mark Hopman - Chief Commercial Officer at Beta Bionics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Issuer Symbol
BBNX on Nasdaq
All Insider Reports
All Insider Reports

Mark Hopman - trading volume in the past year for Beta Bionics, Inc.

Holdings reported by Mark Hopman for Beta Bionics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 34,132 $637,961 $18.69 02 Jun 2025 Direct
Employee Stock Option (right to buy) 21,725 05 Sep 2025 Direct Common Stock

Transactions reported by Mark Hopman for Beta Bionics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.